Sponsor Dossier

Stallergenes

Sponsor Dossier for Stallergenes. ARTG portfolio, PBS-listed brands, PBAC activity, AusPAR record — compiled by arcimedes.

About

Stallergenes is an Australian Private Company with ABN 17 151 366 540, registered in New South Wales. The entity is Active and was previously known as Stallergenes Greer.

Portfolio

Stallergenes has 54 brands on the ARTG, of which 5 are indexable and 4 carry a Product Information document. 1 brand is PBS-listed, 2 have a PBAC outcome on record, and 2 have an AusPAR on record. Notable brands include ACTAIR, ALBEY, ALBUMIN-SALINE, ALTERNARIA, ALUSTAL, AMERICAN, ARIZONA, ASPERGILLUS, BAHIA, BERMUDA, BOTRYTIS, CANDIDA.

Therapeutic focus

— Immunology: 50 brands — Uncategorised: 3 brands — Respiratory: 1 brand

PBS footprint

1 brand is PBS-listed, with the latest PBS schedule date 2026-10-01.

Regulatory activity

The latest PBAC outcome is 2018-07-01, across 2 brands with a PBAC outcome on record. The latest AusPAR is 2017-10-06, across 2 brands with an AusPAR on record.

ABR record